PharmaCorp RxTSXV:PCRX 35 Gross Margin % is 38.84% as of Mar. 2026, which is 0% above its 10-year median of 38.70. GuruFocus rates TSXV:PCRX with a GF Score™ of 35/100. The stock has 2 warning signs investors should review. Among 629 Healthcare Providers & Services companies, PharmaCorp Rx ranks worse than 51.35% on this metric.
The historical rank and industry rank for PharmaCorp Rx's Gross Margin % or its related term are showing as below:
TSXV:PCRX'
s Gross Margin % Range Over the Past 10 Years
Min: 37.69 Med: 38.7 Max: 39.71
Current: 39.32
During the past 5 years, the highestGross Margin % of PharmaCorp Rx was 39.71%. The lowest was 37.69%. And the median was 38.70%.
TSXV:PCRX's Gross Margin % is ranked worse than 51.35% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs TSXV:PCRX: 39.32
PharmaCorp Rx had a gross margin of 38.84% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for PharmaCorp Rx was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
PharmaCorp Rx had a gross margin of 38.84% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
PharmaCorp Rx Gross Margin % Related Terms
PharmaCorp Rx Gross Margin % Historical Data
* Premium members only.
The historical data trend for PharmaCorp Rx's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, PharmaCorp Rx's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaCorp Rx Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PharmaCorp Rx's Gross Margin % distribution charts can be found below:
* The bar in red indicates where PharmaCorp Rx's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
PharmaCorp Rx (TSXV:PCRX) has a Gross Margin % of 38.84% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on PharmaCorp Rx and its competitors. This is near median its historical median of 38.70. Over the past decade, PharmaCorp Rx's Gross Margin % has ranged from 37.69 to 39.71. According to the industry distribution chart, PharmaCorp Rx ranks #323 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 51.4%.
Is PharmaCorp Rx's Gross Margin % too high?
PharmaCorp Rx's current Gross Margin % of 38.84% is near median its 10-year median of 38.70. Over the past 10 years, this metric has ranged from a low of 37.69 to a high of 39.71. The Healthcare Providers & Services industry median Gross Margin % is 40.09. PharmaCorp Rx's value of 38.84% is 3.1% below this industry median. Based on the distribution chart, PharmaCorp Rx ranks #323 out of 629 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PharmaCorp Rx has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Gross Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, PharmaCorp Rx ranks #323 out of 629 companies for Gross Margin %. This places PharmaCorp Rx in the lower half of its industry. The industry median Gross Margin % is 40.09. PharmaCorp Rx's value of 38.84% is 3.1% below this benchmark. Historically, PharmaCorp Rx's own Gross Margin % has ranged from 37.69 to 39.71 over the past decade. While the company's 10-year median is 38.70 vs. the industry median of 40.09, PharmaCorp Rx has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmaCorp Rx's current Gross Margin % of 38.84% is 3.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on PharmaCorp Rx and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaCorp Rx's current Gross Margin % is 38.84%, which is near median its own 10-year median of 38.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Gross Margin % of 38.84%. The current Gross Margin % is 38.84%, which is near median its 10-year median of 38.70 and 3.1% below the Healthcare Providers & Services industry median of 40.09. PharmaCorp Rx's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Gross Margin % is 38.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
35GF Score
Get the complete analysis for TSXV:PCRX
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PCRX has been successfully added to your 
